Immediate point of care HbA1c results for efficient monitoring of glycemic control.
The Afinion™ HbA1c assay is a test for quantitative determination of glycated hemoglobin (HbA1c) in human whole blood, used to monitor metabolic control in patients with diabetes. It provides the immediate test results you need for improved diabetic control, better patient outcomes, and enhanced clinic efficiencies.
The CLIA-Waived Afinion™ HbA1c test gives you reliable, high quality results conveniently available when and where you need them.
Diabetes can be treated and managed by healthful eating, regular physical activity, and medications to lower blood glucose levels. Lowering the HbA1c has been shown to reduce microvascular complications of diabetes and is also associated with long-term reduction in macrovascular disease.
Patient consultations can be carried out with confidence. The HbA1c Test Cartridge contains all reagents necessary for the measurement of glycated hemoglobin. The test has 3 months room temperature storage.
Access this free webcast to learn various methods for measuring plasma glucose and other factors to consider for optimizing patient outcomes. This webcast will elaborate on the cost benefits of using POC HbA1c and help you interpret and assess the impact of POC HbA1c use on patient outcomes, among other learning benefits.
|Afinion™ System Tests||Code|
|Afinion HbA1c, 15 test
|Afinion HbA1c, 15 test||1116797 (NO, SE, DK, FL, IS)
|Afinion HbA1c, 15 test||1116796 (JP)
|Afinion HbA1c, 15 test||1116798 (IN)
|Afinion HbA1c, 15 test||1116795 (Global)|
|Afinion HbA1c Control||1116975 (US)|
|Afinion HbA1c Control||1116793 (Global)|
Sign up to receive valuable updates from Abbott.
Please click NO to return to the homepage. Alternatively, click YES to acknowledge and proceed.
Based on your current location, the content on this page may not be relevant for your country.